diabetes

Abbott’s Diabetes Device Dominates As CEO White Hands Over Reigns
Abbott’s Diabetes Device Dominates As CEO White Hands Over Reigns
Forbes
Abbott Labs
Miles White
Pharma CEOs
devices
FreeStyle Libre
diabetes
Flag link:
JPM: Biotech, VC execs on where the industry should look beyond cancer
JPM: Biotech, VC execs on where the industry should look beyond cancer
Fierce Biotech
oncology
cancer
Alzheimer's disease
diabetes
venture capital
JPMHC 2020
Flag link:
Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication
Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication
Endpoints
Novo Nordisk
Ozempic
diabetes
cardiovascular events
FDA
Flag link:
Tandem Diabetes Launches a New Version of Its Insulin Pump
Tandem Diabetes Launches a New Version of Its Insulin Pump
Motley Fool
Tandem Diabetes
diabetes
insulin pumps
devices
Flag link:
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Motley Fool
Eli Lilly
generics
insulin
diabetes
Lispro
Flag link:
Abbott Kicks in for Bigfoot's $45M Financing
Abbott Kicks in for Bigfoot's $45M Financing
Medical Devices and Diagnostics Industry
Bigfoot Biomedical Abbott Labs
devices
diabetes
Flag link:
FDA OKs Novo's Fiasp for diabetic children
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
insulin
FDA
Novo Nordisk
Fiasp
pediatrics
diabetes
type 1 diabetes
Flag link:
Novo Nordisk Launches $99 Insulin Program
Novo Nordisk Launches $99 Insulin Program
BioSpace
Novo Nordisk
diabetes
insulin
drug pricing
Flag link:
High Cost of Insulin Remains a Concern as Lawmakers Head into 2020 Election
High Cost of Insulin Remains a Concern as Lawmakers Head into 2020 Election
BioSpace
diabetes
insulin
drug pricing
2020 Presidential election
Flag link:
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
Fierce Pharma
Eli Lilly
David Ricks
Pharma CEOs
insulin
patients
diabetes
Flag link:
FDA takes another step to encourage copycat insulin products
FDA takes another step to encourage copycat insulin products
Pharmaforum
FDA
diabetes
insulin
biosimilars
Flag link:
Are Changes in Store for Verily’s Diabetes Joint Venture?
Are Changes in Store for Verily’s Diabetes Joint Venture?
Medical Devices and Diagnostics Industry
Verily
Sanofi
diabetes
Onduo
digital health
Flag link:
Lilly doubles down on Dexcom tech for connected insulin devices
Lilly doubles down on Dexcom tech for connected insulin devices
Pharmaforum
Eli Lilly
DexCom
continuous glucose monitoring
devices
diabetes
Flag link:
Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning
Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning
Motley Fool
Sanofi
M&A
immuno-oncology
Lantus
diabetes
Flag link:
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Flag link:
Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling
Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling
Fierce Pharma
Sanofi
Paul Hudson
Pharma CEOs
diabetes
cardiovascular death
Flag link:
ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
Xtalks
Novo Nordisk
Rybelsus
oral semaglutide
diabetes
ICER
drug pricing
Flag link:
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
AstraZeneca
diabetes
type 2 diabetes
heart failure
Flag link:
Why Diabetes Stock Insulet Soared 28% in November
Why Diabetes Stock Insulet Soared 28% in November
Motley Fool
Insulet
devices
diabetes
Omnipod
insulin pumps
Flag link:
FDA guidance finally opens door for insulin biosimilars
FDA guidance finally opens door for insulin biosimilars
Pharmaforum
FDA
insulin
biosimilars
diabetes
Flag link:

Pages